These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13916941)

  • 1. [Comparative studies on the method for the purification of immune antitumor sera].
    STEPINA VN
    Vopr Onkol; 1962; 8(2)():12-5. PubMed ID: 13916941
    [No Abstract]   [Full Text] [Related]  

  • 2. [ULTRASTRUCTURAL CELL CHANGES IN GUERIN'S CARCINOMA UNDER THE INFLUENCE OF ANTITUMOR SERA].
    UMANSKII IuA; PINCHUK VG; MONASTYRSKAIA BD
    Dokl Akad Nauk SSSR; 1965; 161():221-3. PubMed ID: 14283485
    [No Abstract]   [Full Text] [Related]  

  • 3. [POTENTIATIES OF THE ANTITUMOR ACTIVITY OF SARCOLYSIN BY HETEROLOGOUS IMMUNE SERUMS].
    BONMASSAR E; DIROBERTO F; CELI ML; PRADA A
    Arch Ital Patol Clin Tumori; 1964; 152():291-301. PubMed ID: 14265674
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDY OF THE ANTIGEN STRUCTURE OF HUMAN TUMORS. II. PURIFICATION OF SPECIFIC IMMUNE SERA TO HUMAN STOMACH CANCER].
    TSVETKOV VS; LIUDOGOVSKAIA LA
    Vopr Onkol; 1964; 10():16-8. PubMed ID: 14162762
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic effects of antitumor serum.
    WISSLER RW; FLAX MH
    Ann N Y Acad Sci; 1957 Dec; 69(4):773-94. PubMed ID: 13488329
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined effects of antitumor serum and other therapy on the growth and appearance of tumors.
    WISSLER RW
    Cancro; 1961; 14():433-40. PubMed ID: 14007704
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE ANTIGEN STRUCTURE OF HUMAN TUMORS. III. COMPARATIVE ANALYSIS OF STOMACH CANCER TISSUE].
    LIUDOGOVSKAIA LA; TSVETKOV VS; KIRIUKHIN VP
    Vopr Onkol; 1964; 10():18-22. PubMed ID: 14162763
    [No Abstract]   [Full Text] [Related]  

  • 8. [Method of production of immune serum specific to human cancer].
    KOSIAKOV PN; KOROSTELEVA VS; KUZNETSOVA NI
    Biull Eksp Biol Med; 1955 Sep; 40(9):63-5. PubMed ID: 13276474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Production of anti-cancer sera of narrow specificity].
    NAZARENKO NA
    Vopr Onkol; 1960; 6(3)():14-8. PubMed ID: 14426259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Still on immunology of an experimental tumor of the mouse: attempts at protection by means of immune serums].
    Serafini NA; Ferrari S
    Ann Ist Carlo Forlanini; 1965; 25(3):305-8. PubMed ID: 5863699
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical studies of antibodies in anti-Murphy lymphosarcoma sera.
    HIRAMOTO R; YAGI Y; PRESSMAN D
    Cancer Res; 1959 Sep; 19():874-9. PubMed ID: 14401940
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDY OF ANTI-TUMOR ANTIBODIES FOUND IN RABBIT ANTI-HUMAN GASTRIC TUMOR IMMUNE SERUMS AND PRELIMINARY OBSERVATIONS CONCERNING THE AUTOANTIBODIES FOUND IN THE SERUMS OF PATIENTS WITH GASTRIC CANCER].
    BONATTI A; RAPP W; BURTIN P
    C R Hebd Seances Acad Sci; 1964 Jun; 258():6023-6. PubMed ID: 14183160
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of antitumour factors in homologous and heterologous immune systems.
    SEKLA B; HOLECKOVA E
    Acta Unio Int Contra Cancrum; 1962; 18():76-9. PubMed ID: 13910385
    [No Abstract]   [Full Text] [Related]  

  • 14. [TREATMENT RESEARCH WITH IMMUNE SERUMS IN RATS BEARING EXPERIMENTALLY TRANSPLANTED TUMORS. (EXPERIMENTAL RESEARCH). V].
    TENDELLA E; GELMI G
    Acta Chir Ital; 1963; 19():1167-77. PubMed ID: 14121897
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON OBTAINING SPECIFIC ANTI-CANCER SERUMS].
    SAAKOV AK
    Biull Eksp Biol Med; 1963 Sep; 56():95-8. PubMed ID: 14124795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acquired immunological tolerance as a basis for the production of specific anti-cancer sera].
    MOL'KOV IU N
    Neoplasma; 1959; 6():113-24. PubMed ID: 14423325
    [No Abstract]   [Full Text] [Related]  

  • 17. [CHANGES INDUCED BY MEANS OF PREVENTIVE TREATMENT, WITH IMMUNE SERUMS BEFORE AND AFTER TRANSPLANTATION OF TUMOR GRAFTS IN RATS. (EXPERIMENTAL RESEARCH). VI].
    GELMI G; TENDELLA E
    Acta Chir Ital; 1963; 19():1179-89. PubMed ID: 14121898
    [No Abstract]   [Full Text] [Related]  

  • 18. CYTOTOXIC EFFECTS OF COMPLEMENT AND IMMUNE SERA PREPARED AGAINST EPITHELIAL- AND FIBROBLAST-LIKE CELL STRAINS.
    GROENROOS JA; MUSTAKALLIO E
    Ann Med Exp Biol Fenn; 1963; 41():399-406. PubMed ID: 14085825
    [No Abstract]   [Full Text] [Related]  

  • 19. The differentiation of cytotoxic and hemagglutinating antibodies in anti-HeLa cell rabbit sera.
    GOLDSTEIN G; MYRVIK QN
    J Immunol; 1960 Jun; 84():659-61. PubMed ID: 13850764
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific tumour immunity and its use in the immunotherapy of experimental tumours.
    KOLDOVSKY P
    Acta Unio Int Contra Cancrum; 1962; 18():87-8. PubMed ID: 14457972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.